AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15738298 — intervention group
Group type: COMPARATOR
Intervention: Placebo and sham treatment
Number of subjects: 10
Study 15321623 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolic deterrent stockings (TED) and sequential compression device (SCD)
Number of subjects: 0
Study 15321623 — intervention group
Group type: COMPARATOR
Intervention: Control (no TED/SCD)
Number of subjects: 0
Study 9842764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic group D1
Number of subjects: 185
Study 9842764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic group D2
Number of subjects: 185
Study 9842764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dyslexic groups
Number of subjects: 185
Study 9842764 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185
Study 9842764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic groups
Number of subjects: 185
Study 9842764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexic group D1 and D2
Number of subjects: 185
Study 7511106 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg t.i.d.)
Number of subjects: 24
Study 7511106 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 24
Study 2499203 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg praziquantel
Number of subjects: 280
Study 2499203 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg praziquantel
Number of subjects: 280
Study 2499203 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg praziquantel
Number of subjects: 280
Study 2499203 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg praziquantel
Number of subjects: 280
Study 29858412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ten Top Tips
Number of subjects: 15
Study 29858412 — intervention group
Group type: EXPERIMENTAL
Intervention: Do Something Different
Number of subjects: 15
Study 27587528 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibular nail
Number of subjects: 100
Study 27587528 — intervention group
Group type: COMPARATOR
Intervention: Standard ORIF
Number of subjects: 100
Study 23362335 — intervention group
Group type: EXPERIMENTAL
Intervention: Clown intervention (children accompanied by parents and two clowns)
Number of subjects: 196
Study 23362335 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (children accompanied by parents only)
Number of subjects: 196
Study 22848346 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical male circumcision (MMC)
Number of subjects: 59
Study 22848346 — intervention group
Group type: EXPERIMENTAL
Intervention: GUD of unknown etiology
Number of subjects: 59
Study 22848346 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusobacteria (Fusobacterium spp. and Sneathia spp.)
Number of subjects: 59
Study 22848346 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxobacter spp. and Anaerovorax spp.
Number of subjects: 59
Study 22848346 — intervention group
Group type: COMPARATOR
Intervention: Uncircumcised men
Number of subjects: 59
Study 19751234 — intervention group
Group type: EXPERIMENTAL
Intervention: Home parental programme (HPP) lasting approximately 12 weeks, involving visual-motor activities at home.
Number of subjects: 45
Study 19751234 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving consultation in the classroom only.
Number of subjects: 45
Study 19751234 — intervention group
Group type: EXPERIMENTAL
Intervention: Home parental programme (HPP)
Number of subjects: 45
Study 18771484 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 490
Study 18771484 — intervention group
Group type: EXPERIMENTAL
Intervention: 9‐OH risperidone
Number of subjects: 490
Study 16084181 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to drug samples
Number of subjects: 29
Study 16084181 — intervention group
Group type: COMPARATOR
Intervention: No access to drug samples
Number of subjects: 29
Study 12120185 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 0
Study 12120185 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod
Number of subjects: 0
Study 9732652 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 252
Study 9732652 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study 9732652 — intervention group
Group type: COMPARATOR
Intervention: Comparison group 1
Number of subjects: 252
Study 9732652 — intervention group
Group type: COMPARATOR
Intervention: Comparison group 2
Number of subjects: 252
Study 8277302 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer-delivered case management services
Number of subjects: 0
Study 8277302 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in social activities
Number of subjects: 0
Study 3176837 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.6 mg in 20 ml NaCl)
Number of subjects: 32
Study 3176837 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (0.4 mg in 20 ml NaCl)
Number of subjects: 32
Study 31743542 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% BOI lotion (ceramide HS) applied once a day for 6 months
Number of subjects: 58
Study 29122255 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 55
Study 29122255 — intervention group
Group type: EXPERIMENTAL
Intervention: Diadynamic currents (DD)
Number of subjects: 55
Study 25240788 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigator intervention (up to five home visits)
Number of subjects: 64
Study 25240788 — intervention group
Group type: COMPARATOR
Intervention: Control group (received a packet of linguistically matched materials on palliative care)
Number of subjects: 64
Study 22905878 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel (up to 12 mg/day)
Number of subjects: 1218
Study 22905878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1218
Study 20860867 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 58
Study 20860867 — intervention group
Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (Control)
Number of subjects: 58
Study 19579946 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation (15 drops)
Number of subjects: 100
Study 19579946 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (30 drops)
Number of subjects: 100
Study 19579946 — intervention group
Group type: COMPARATOR
Intervention: Comparison of daily vs weekly iron supplementation
Number of subjects: 100
Study 17998182 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally-invasive total knee replacement (TKR) approaches (quadriceps-sparing and sub-vastus)
Number of subjects: 198
Study 17998182 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 198
Study 14982566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (270 mg)
Number of subjects: 15
Study 14982566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11338024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (pleuropneumonectomy) followed by sequential chemotherapy and radiotherapy
Number of subjects: 3000
Study 11338024 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 3000
Study 11338024 — intervention group
Group type: COMPARATOR
Intervention: Single-modality therapy (surgery, radiotherapy, chemotherapy)
Number of subjects: 3000
Study 9635532 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient reminder intervention
Number of subjects: 5801
Study 9635532 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician reminder intervention
Number of subjects: 5801
Study 8170529 — intervention group
Group type: EXPERIMENTAL
Intervention: quazepam (15-30 mg, median 15 mg)
Number of subjects: 45
Study 8170529 — intervention group
Group type: EXPERIMENTAL
Intervention: triazolam (0.25-0.5 mg, median 0.25 mg)
Number of subjects: 45
Study 8170529 — intervention group
Group type: EXPERIMENTAL
Intervention: quazepam
Number of subjects: 45
Study 8170529 — intervention group
Group type: EXPERIMENTAL
Intervention: triazolam
Number of subjects: 45
Study 8170529 — intervention group
Group type: COMPARATOR
Intervention: both drugs
Number of subjects: 45
Study 29802174 — intervention group
Group type: EXPERIMENTAL
Intervention: Huaier granule
Number of subjects: 1044
Study 29802174 — intervention group
Group type: COMPARATOR
Intervention: Control (no further treatment)
Number of subjects: 1044
Study 27603376 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (R)
Number of subjects: 82
Study 27603376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine with fentanyl (R + F)
Number of subjects: 82
Study 24871477 — intervention group
Group type: EXPERIMENTAL
Intervention: Provegetarian food pattern (FP)
Number of subjects: 7216
Study 24871477 — intervention group
Group type: EXPERIMENTAL
Intervention: Updated information on diet
Number of subjects: 7216
Study 23171639 — intervention group
Group type: EXPERIMENTAL
Intervention: EMiC2 dialyzer
Number of subjects: 11
Study 23171639 — intervention group
Group type: COMPARATOR
Intervention: AV 1000S dialyzer
Number of subjects: 11
Study 20466802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beet root juice (BR, 5.1 mmol of NO(3)(‐)/day)
Number of subjects: 7
Study 20466802 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beet root juice (BR)
Number of subjects: 7
Study 18776000 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (SCD-HeFT)
Number of subjects: 0
Study 18776000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy alone (COMPANION)
Number of subjects: 0
Study 18776000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy plus implantable cardioverter defibrillator (COMPANION)
Number of subjects: 0
Study 18776000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy alone (CARE-HF)
Number of subjects: 0
Study 17161052 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 2457
Study 17161052 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive treatment strategy
Number of subjects: 2457
Study 14576886 — intervention group
Group type: EXPERIMENTAL
Intervention: AD syringe only
Number of subjects: 15
Study 14576886 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed (AD syringes used only on non-routine immunization days)
Number of subjects: 15
Study 14576886 — intervention group
Group type: COMPARATOR
Intervention: Sterilizable syringe only (control)
Number of subjects: 15
Study 10805207 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) via dry powder inhaler (Clickhaler)
Number of subjects: 240
Study 10805207 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) via pressurized metered-dose inhaler (MDI)
Number of subjects: 240
Study 10805207 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) via Clickhaler
Number of subjects: 240
Study 8828933 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular replacement of lenses every 3 months
Number of subjects: 39
Study 8828933 — intervention group
Group type: COMPARATOR
Intervention: No scheduled replacement of lenses
Number of subjects: 39
Study 1349062 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help rehabilitation programme based on a heart manual
Number of subjects: 176
Study 1349062 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus placebo package of information and informal counselling
Number of subjects: 176
Study 3881203 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3, 0.50 micrograms a day
Number of subjects: 70
Study 3881203 — intervention group
Group type: COMPARATOR
Intervention: Cyclical estrogen/gestagen
Number of subjects: 70
Study 3881203 — intervention group
Group type: COMPARATOR
Intervention: Placebo + calcium
Number of subjects: 70
Study 30706142 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovingkindness meditation
Number of subjects: 60
Study 30706142 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 60
Study 30706142 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 30408351 — intervention group
Group type: EXPERIMENTAL
Intervention: MJ-Abst (4 weeks of cannabis abstinence, n = 62)
Number of subjects: 88
Study 30408351 — intervention group
Group type: COMPARATOR
Intervention: MJ-Mon (monitoring control condition, n = 26)
Number of subjects: 88
Study 27009822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral NTHi vaccine (HI-164OV)
Number of subjects: 320
Study 27009822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 24769011 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 1258
Study 24769011 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1258
Study 24769011 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes group
Number of subjects: 1258
Study 24769011 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hypertension group
Number of subjects: 1258
Study 24769011 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple gestation group
Number of subjects: 1258
Study 24769011 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous preeclampsia group
Number of subjects: 1258
Study 23144819 — intervention group
Group type: EXPERIMENTAL
Intervention: CRS patients with complement defects
Number of subjects: 87
Study 23144819 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 87
Study 19943984 — intervention group
Group type: EXPERIMENTAL
Intervention: Champagne wine consumption
Number of subjects: 0
Study 19943984 — intervention group
Group type: COMPARATOR
Intervention: Control matched for alcohol, carbohydrate and fruit-derived acid content
Number of subjects: 0
Study 17106718 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral isometric handgrip (IHG) training, 4 contractions at 30% of maximal voluntary effort, 3 times per week for 8 weeks.
Number of subjects: 16
Study 17106718 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral isometric handgrip (IHG) training, 4 contractions at 30% of maximal voluntary effort, 3 times per week for 8 weeks.
Number of subjects: 16
Study 15741989 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine 1 g orally three times a day for 12 weeks
Number of subjects: 35
Study 15741989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 12067941 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori CagA seropositivity in cases (n=201)
Number of subjects: 615
Study 12067941 — intervention group
Group type: COMPARATOR
Intervention: H pylori CagA seropositivity in controls (n=414)
Number of subjects: 615
Study 12067941 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted analysis for cases
Number of subjects: 615
Study 12067941 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline inflammatory markers in cases and controls
Number of subjects: 615
Study 9800081 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation therapy
Number of subjects: 16
Study 7638371 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 25, 50, and 75 micrograms
Number of subjects: 12
Study 7638371 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12, 24, and 36 micrograms
Number of subjects: 12
Study 7638371 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 micrograms
Number of subjects: 12
Study 7638371 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 12 and 24 micrograms
Number of subjects: 12
Study 2374566 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid diet
Number of subjects: 59
Study 2374566 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-fatty-acid diet
Number of subjects: 59
Study 2374566 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated-fat diet
Number of subjects: 59
Study 361463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol (2 mg/day for 12 weeks)
Number of subjects: 46
Study 361463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 361463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazindol
Number of subjects: 46
Study 30773048 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational audio intervention
Number of subjects: 713
Study 31600103 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocellulose wound dressing
Number of subjects: 4
Study 31600103 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxymethyl cellulose wound dressing
Number of subjects: 4
Study 31600103 — intervention group
Group type: COMPARATOR
Intervention: Normal saline wound dressing
Number of subjects: 4
Study 28619061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 1 g intravenously, twice at an interval of 2 weeks
Number of subjects: 116
Study 28619061 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide 600 mg/m2 body surface area intravenously, given monthly
Number of subjects: 116
Study 28619061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 116
Study 28619061 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 116
Study 26341455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (fasting for 4 hours after endoscopic therapy)
Number of subjects: 70
Study 26341455 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding (fasting for 48 hours after endoscopic therapy)
Number of subjects: 70
Study 26341455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 70
Study 26341455 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding
Number of subjects: 70
Study 24045029 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination induction
Number of subjects: 81
Study 24045029 — intervention group
Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 81
Study 20427425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of a megadose of cholecalciferol (10,000 IU kg(‐1), max 600,000 IU)
Number of subjects: 40
Study 20427425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of a megadose of cholecalciferol
Number of subjects: 40
Study 18777031 — intervention group
Group type: EXPERIMENTAL
Intervention: AS100 vaccine
Number of subjects: 2770
Study 16919747 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate (LAAM), 255-391 mg
Number of subjects: 137
Study 16919747 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP), 56-112 mg
Number of subjects: 137
Study 16919747 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (METH), 420-700 mg
Number of subjects: 137
Study 12472796 — intervention group
Group type: COMPARATOR
Intervention: Conventional PD fluid (heat sterilized at pH 5.5)
Number of subjects: 0
Study 12472796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low GDP PD fluid (sterilized using a multicompartment bag system)
Number of subjects: 0
Study 10708158 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermic CPB (34 degrees C)
Number of subjects: 0
Study 10708158 — intervention group
Group type: COMPARATOR
Intervention: Moderate hypothermic CPB (28 degrees C)
Number of subjects: 0
Study 9105981 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural narcotics (Group 1, n = 26)
Number of subjects: 52
Study 9105981 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural narcotics (Group 2, n = 26)
Number of subjects: 52
Study 9105981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received 5 mg of epidural morphine after intubation
Number of subjects: 52
Study 8478661 — intervention group
Group type: COMPARATOR
Intervention: IL-2/IFN (IL-2 0.8 mg/m2 and IFN 3 x 10(6) U/m2)
Number of subjects: 71
Study 8478661 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 alone (1.33 mg/m2)
Number of subjects: 71
Study 2429335 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg piroxicam each morning
Number of subjects: 40
Study 2429335 — intervention group
Group type: COMPARATOR
Intervention: 250 mg naproxen twice daily
Number of subjects: 40
Study 2429335 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (conservative treatment)
Number of subjects: 40
Study 30870105 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit condition (assessing automatic suppression)
Number of subjects: 126
Study 30870105 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit condition (assessing controlled suppression)
Number of subjects: 126
Study 30870105 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 126
Study 28598933 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary workplace shoulder exercise program
Number of subjects: 76
Study 28598933 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar departments without exercise program)
Number of subjects: 76
Study 25692797 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for medication adherence
Number of subjects: 78
Study 22978687 — intervention group
Group type: EXPERIMENTAL
Intervention: TSH >30 μU/mL after 4 weeks of thyroid hormone withdrawal (THW)
Number of subjects: 47
Study 22978687 — intervention group
Group type: EXPERIMENTAL
Intervention: TSH >80-100 μU/mL after 4 weeks of THW
Number of subjects: 47
Study 22978687 — intervention group
Group type: EXPERIMENTAL
Intervention: FACIT-F questionnaire
Number of subjects: 47
Study 22978687 — intervention group
Group type: EXPERIMENTAL
Intervention: TSH >20 μU/mL with Tg <0.2 ng/mL
Number of subjects: 47
Study 21300969 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulated leisure-time sun exposure (age 6 years to current)
Number of subjects: 216
Study 21300969 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher actinic skin damage (highest grade vs the lowest)
Number of subjects: 216
Study 19758258 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% ethylenediaminetetracetic acid (EDTA)
Number of subjects: 66
Study 19758258 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 66
Study 19758258 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% sodium chloride (NaCl)
Number of subjects: 66
Study 16816226 — intervention group
Group type: EXPERIMENTAL
Intervention: Family focused grief therapy (53 families, 233 individuals)
Number of subjects: 81